Can a simple blood test predict liver health in PBC patients?
NCT ID NCT07449793
First seen Mar 10, 2026 · Last updated May 25, 2026 · Updated 14 times
Summary
This study looks at 3,000 people with primary biliary cholangitis (PBC) to see if changes in a blood marker called alkaline phosphatase after treatment are linked to better survival without serious liver problems. Researchers will track participants over time to build a model that predicts outcomes. The goal is to improve how doctors monitor and treat PBC.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PRIMARY BILIARY CHOLANGITIS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
RenJi Hospital
RECRUITINGShanghai, Shanghai Municipality, 200001, China
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.